Endurant Capital Management LP Bellus Health Inc. Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$5.26 - $8.3 $2.05 Million - $3.24 Million
-389,833 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$2.7 - $6.64 $45,100 - $110,914
-16,704 Reduced 4.11%
389,833 $2.39 Million
Q2 2021

Aug 16, 2021
BUY
$3.11 - $4.61 $288,303 - $427,356
92,702 Added 29.54%
406,537 $1.26 Million
Q1 2021

May 17, 2021
BUY
$3.03 - $4.58 $950,920 - $1.44 Million
313,835 New
313,835 $1.21 Million

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0
View Full List

About BELLUS Health Inc.

BLU Quotes by TradingView
  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email